Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: MicroRNAs are a family of 19- to 25-nucleotides noncoding small RNAs that primarily function as gene regulators. Aberrant microRNA expression has been described for several human malignancies, and this new class of small regulatory RNAs has both oncogenic and tumor suppressor functions. Despite this knowledge, there is little information regarding microRNAs in plasma especially because microRNAs in plasma, if exist, were thought to be digested by RNase. Recent studies, however, have revealed that microRNAs exist and escape digestion in plasma. METHODOLOGY/PRINCIPAL FINDINGS: We performed microRNA microaray to obtain insight into microRNA deregulation in the plasma of a leukemia patient. We have revealed that microRNA-638 (miR-638) is stably present in human plasmas, and microRNA-92a (miR-92a) dramatically decreased in the plasmas of acute leukemia patients. Especially, the ratio of miR-92a/miR-638 in plasma was very useful for distinguishing leukemia patients from healthy body. CONCLUSIONS/SIGNIFICANCE: The ratio of miR-92a/miR-638 in plasma has strong potential for clinical application as a novel biomarker for detection of leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 1×
“have the capacity to release exosomes, and exosomes contain both mRNAs and microRNAs, which can be delivered to another cell and function in a new location”
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · cited 1×
“Many cells including reticulocytes [25], dendritic cells [26], B cells [27], T cells [28], mast cells [29], epithelial cells [30] and tumor cells [31] have the capacity to release exosomes, and exosomes contain both mRNAs and microRNAs, which can be delivered to another cell and function in a new location [32].”
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Mattick, J. S., & Makunin, I. V. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl046 · Cited by 2,453
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082 · cited 1×
“These single-strand RNAs are considered to play crucial roles in many normal cellular processes, such as proliferation, development, differentiation and apoptosis by inhibiting target gene(s) expression through imperfect pairing with target mRNAs, inducing direct mRNA degradation or translational inhibition [2,3,4,5].”
Pan, B.-T., & Johnstone, R. M. (1983) · Cell · doi:10.1016/0092-8674(83)90040-5 · Cited by 2,032
Cited by
MicroRNAs in body fluids—the mix of hormones and biomarkers
Cortez, M. A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A. K., & Calin, G. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.76 · Cited by 1,465
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.226357 · Cited by 1,283
Wang, G.-K., Zhu, J.-Q., Zhang, J.-T., Li, Q., Li, Y., He, J., Qin, Y.-W., & Jing, Q. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq013 · Cited by 1,170
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W., & Du, X. (2010) · International Journal of Cancer · doi:10.1002/ijc.25007 · Cited by 964
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P. G., Rubino, M., Carena, M. C., Spazzafumo, L., De Simone, M., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq167 · Cited by 797
Circulating miRNAs are correlated with tumor progression in prostate cancer
Brase, J. C., Johannes, M., Schlomm, T., Fälth, M., Haese, A., Steuber, T., Beissbarth, T., Kuner, R., & Sültmann, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25376 · Cited by 587
Ohshima, K., Inoue, K., Fujiwara, A., Hatakeyama, K., Kanto, K., Watanabe, Y., Muramatsu, K., Fukuda, Y., Ogura, S.-I., Yamaguchi, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013247 · Cited by 577
Circulating microRNAs: Association with disease and potential use as biomarkers
Reid, G., Kirschner, M. B., & van Zandwijk, N. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.11.004 · Cited by 467
Cheng, H., Zhang, L., Cogdell, D. E., Zheng, H., Schetter, A. J., Nykter, M., Harris, C. C., Chen, K., Hamilton, S. R., & Zhang, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017745 · Cited by 430
Serum microRNAs as non-invasive biomarkers for cancer
Brase, J. C., Wuttig, D., Kuner, R., & Sültmann, H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-306 · Cited by 421
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
ALLEGRA, A., ALONCI, A., CAMPO, S., PENNA, G., PETRUNGARO, A., GERACE, D., & MUSOLINO, C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1647 · Cited by 359
The Impact of Hemolysis on Cell-Free microRNA Biomarkers
Kirschner, M. B., Edelman, J. J. B., Kao, S. C.-H., Vallely, M. P., van Zandwijk, N., & Reid, G. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00094 · Cited by 352
Bianchi, F., Nicassio, F., Marzi, M., Belloni, E., Dall'Olio, V., Bernard, L., Pelosi, G., Maisonneuve, P., Veronesi, G., & Di Fiore, P. P. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100154 · Cited by 351
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Yaman Agaoglu, F., Kovancilar, M., Dizdar, Y., Darendeliler, E., Holdenrieder, S., Dalay, N., & Gezer, U. (2011) · Tumor Biology · doi:10.1007/s13277-011-0154-9 · Cited by 341
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Hamam, R., Hamam, D., Alsaleh, K. A., Kassem, M., Zaher, W., Alfayez, M., Aldahmash, A., & Alajez, N. M. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.440 · Cited by 322
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
Barutta, F., Tricarico, M., Corbelli, A., Annaratone, L., Pinach, S., Grimaldi, S., Bruno, G., Cimino, D., Taverna, D., Deregibus, M. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073798 · Cited by 317
Circulating MicroRNAs as Noninvasive Biomarkers in Breast Cancer
Cortez, M. A., Welsh, J. W., & Calin, G. A. (2012) · Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_13 · Cited by 310
Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
Duttagupta, R., Jiang, R., Gollub, J., Getts, R. C., & Jones, K. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020769 · Cited by 307
Diabetes mellitus, a microRNA-related disease?
Guay, C., Roggli, E., Nesca, V., Jacovetti, C., & Regazzi, R. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.009 · Cited by 300
The role of exosomes and miRNAs in drug‐resistance of cancer cells
Bach, D., Hong, J., Park, H. J., & Lee, S. K. (2017) · International Journal of Cancer · doi:10.1002/ijc.30669 · Cited by 296
An, T., Qin, S., Xu, Y., Tang, Y., Huang, Y., Situ, B., Inal, J. M., & Zheng, L. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27522 · Cited by 282
Human Traumatic Brain Injury Alters Plasma microRNA Levels
Redell, J. B., Moore, A. N., Ward, N. H., Hergenroeder, G. W., & Dash, P. K. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1481 · Cited by 282
Micromarkers: miRNAs in cancer diagnosis and prognosis
Ferracin, M., Veronese, A., & Negrini, M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.11 · Cited by 266
Small RNAs have a large impact: Circulating microRNAs as biomarkers for human diseases
Weiland, M., Gao, X.-H., Zhou, L., & Mi, Q.-S. (2012) · RNA Biology · doi:10.4161/rna.20378 · Cited by 265
Takeshita, N., Hoshino, I., Mori, M., Akutsu, Y., Hanari, N., Yoneyama, Y., Ikeda, N., Isozaki, Y., Maruyama, T., Akanuma, N., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.8 · Cited by 262
U6 is not a suitable endogenous control for the quantification of circulating microRNAs
Xiang, M., Zeng, Y., Yang, R., Xu, H., Chen, Z., Zhong, J., Xie, H., Xu, Y., & Zeng, X. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.064 · Cited by 259
Serum microRNAs as powerful cancer biomarkers
Wittmann, J., & Jäck, H.-M. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.07.002 · Cited by 257
miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Ueda, S., Takanashi, M., & Kuroda, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02081.x · Cited by 243
Self-citationNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M., Araujo, A., Araiz, M., Fernandez-Mercado, M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050627 · Cited by 239
“Circulating miR-221/-222 levels have been identified as diagnostic markers in prostate cancer [96], colorectal carcinoma [87,231], NK/T-cell lymphoma [104], liver carcinoma [111], larynx cancer [233], glio a [234], and melanoma [235].”
BackgroundInfluentialGui, J., Tian, Y., Wen, X., Zhang, W., Zhang, P., Gao, J., Run, W., Tian, L., Jia, X., & Gao, Y. (2011) · Clinical Science · doi:10.1042/cs20100297 · Cited by 222
Alsaweed, M., Hartmann, P., Geddes, D., & Kakulas, F. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph121113981 · Cited by 220
Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer
Liu, G.-H., Zhou, Z.-G., Chen, R., Wang, M.-J., zhou, B., Li, Y., & Sun, X.-F. (2013) · Tumor Biology · doi:10.1007/s13277-013-0753-8 · Cited by 213
“[21] showed that miR-92a was dramatically decreased in the plasma of acute leukemia patients using miR-638 as internal control.”
MethodCirculating microRNAs as potential biomarkers for endometriosis
Cho, S., Mutlu, L., Grechukhina, O., & Taylor, H. S. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.02.013 · Cited by 181
Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
Luo, X., Stock, C., Burwinkel, B., & Brenner, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062880 · Cited by 177
Liu, Y., Gao, G., Yang, C., Zhou, K., Shen, B., Liang, H., & Jiang, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610567 · Cited by 164
Circulating microRNAs as Promising Tumor Biomarkers
(2014) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2014.09.007 · Cited by 40
Metadata
- Authors
- Tanaka, M., Oikawa, K., Takanashi, M., Kudo, M., Ohyashiki, J., Ohyashiki, K., & Kuroda, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-05-14
- Volume
- 4
- Issue
- 5
- Pages
- e5532
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2028831862
- Cited by
- 298
- References
- 31
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.